Signant Health Acquires Ametris (Formerly ActiGraph) to Build End-to-End eCOA and Wearables Platform

EvidenceCare Acquires Agathos

March 12, 2025

Healthcare Services

EvidenceCare, a Nashville-based clinical decision support provider, has acquired Agathos, a Boulder-based physician engagement and analytics platform. The deal integrates Agathos’ physician-level analytics and engagement capabilities into EvidenceCare’s EHR-integrated CDSS to expand clinical analytics and physician performance insights.

Lafayette Instrument Acquires Actimetrics

December 19, 2023

Medical Devices

Lafayette Instrument Company, a portfolio company of Branford Castle Partners, has acquired Actimetrics, a Wilmette, Illinois-based maker of scientific instrumentation and software for circadian biology and animal behavioral neuroscience. Brookside Capital Partners provided subordinated debt and minority equity to support Lafayette in the bolt-on acquisition; terms were not disclosed.

Emmes Acquires Essex Management

March 21, 2023

Healthcare Services

Emmes, a global full-service clinical research organization, acquired Essex Management, a bioinformatics and health information technology consultancy, to enhance Emmes' data, bioinformatics and HIT capabilities. The acquisition adds more than 100 employees and expands Emmes' ability to serve government, academic and biopharma clients, including continued support for the National Cancer Institute.

ACA Group Acquires Ethos ESG

September 21, 2022

Data & Analytics

ACA Group has acquired Ethos ESG, a provider of ESG ratings data and analytics for financial advisors, asset managers and institutional investors. The acquisition is ACA's first analytics offering and will be integrated into its ESG Advisory practice to provide data-driven analysis, impact ratings and automated ESG reporting; financial terms were not disclosed.

ERT Acquires APDM Wearable Technologies

June 10, 2020

Medical Devices

ERT, a global clinical endpoints data and technology company, has acquired APDM Wearable Technologies, a provider of medical-grade wearable sensors and digital biomarkers. The deal integrates APDM's Opal sensors and analytics with ERT's eCOA and clinical data platforms to expand objective endpoint measurement in movement disorder and CNS trials; financial terms were not disclosed.

ARCHIMED Acquires 75% Stake in ActiGraph

May 18, 2020

Medical Devices

ARCHIMED (ArchiMed) has acquired a 75% stake in ActiGraph in an all-equity transaction, with management retaining 10% and other historic shareholders keeping 15%. The investment will fund ActiGraph's expansion into the regulated drug-development and clinical-trials market, accelerating product, regulatory and commercial capabilities; financial terms were not disclosed.